Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jan;98(3):e14101.
doi: 10.1097/MD.0000000000014101.

Growth hormone replacement therapy improves hypopituitarism-associated hypoxemia in a patient after craniopharyngioma surgery: A case report

Wenting Qi  1 , Feng Gu, Chuyue Wu
Affiliations
Case Reports

Growth hormone replacement therapy improves hypopituitarism-associated hypoxemia in a patient after craniopharyngioma surgery: A case report

Wenting Qi et al. Medicine (Baltimore). 2019 Jan.

Abstract

Rationale: There are some reports about hypoxemia related to hypopituitarism. However, little is known about the relationship between growth hormone deficiency (GHD) and hypoxemia.

Patients concerns: A 23-year-old female presented with severe hypoxemia after the operations of craniopharyngioma. Laboratory tests found that serum growth hormone (GH) levels were extremely low.

Diagnosis: She was diagnosed with growth hormone deficiency-related hypoxemia.

Interventions: In addition to oxygenation, low doses of GH replacement therapy was conducted for 3-month.

Outcomes: After 3-month r-hGH replacement therapy, hypoxemia was improved significantly and the level of serum GH was elevated.

Lessons: We've already known that hypopituitarism may induce hypoxemia owing to multiple possible mechanisms according to previous literature. But little is known about growth hormone deficiency-related hypoxemia. Our case shows that GH replacement therapy is an effective treatment, and it's significant to examination the level of GH in serum for hypoxemia patients especially when the cause of hypoxemia is unknown.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Changes in the serum levels of GH and IGF-1 over time under the GH replacement therapy. GH = growth hormone, IGF = insulin-like growth factors-1.
See this image and copyright information in PMC

References

    1. Jain BP, Brody JS, Fisher AB. The small lung of hypopituitarism. Am Rev Respir Dis 1973;108:49–55. - PubMed
    1. Siafakas NM, Bouros D. Respiratory muscles in endocrinopathies. Respir Med 1993;87:351–8. - PubMed
    1. Behnia M, Clay AS, Farber MO. Management of myxedematous respiratory failure: review of ventilation and weaning principles. Am J Med Sci 2000;320:368–73. - PubMed
    1. Siafakas NM, Salesiotou V, Filaditaki V, et al. Respiratory muscle strength in hypothyroidism. Chest 1992;102:189–94. - PubMed
    1. Felbinger TW, Suchner U, Goetz AE, et al. Recombinant human growth hormone for reconditioning of respiratory muscle after lung volume reduction surgery. Crit Care Med 1999;27:1634–8. - PubMed

Publication types

MeSH terms

Substances